Literature DB >> 18766471

Poorly differentiated thyroid carcinoma: diagnostic features and controversial issues.

Marco Volante1, Ida Rapa, Mauro Papotti.   

Abstract

Poorly differentiated thyroid carcinomas are a heterogeneous group of tumors occupying an area intermediate between well-differentiated follicular or papillary carcinoma and anaplastic carcinomas, from both a histopathogenetic and a clinical point of view. Large tumor series selected on the basis of structural and/or other morphological criteria showed that poorly differentiated carcinomas have a distinct biological behavior, and the classification of these tumors into a separate group appears justified, although strict homogeneous diagnostic criteria should be achieved and widely accepted to better characterize such tumor entity. Moreover, the identification of the prognostic parameters segregating aggressive from indolent cases has important clinical implications. Molecular data in the literature, although limited by the heterogeneous case series analyzed, identify ras alterations as the most common molecular alteration in poorly differentiated carcinomas, thus, depicting a peculiar molecular pathway in this tumor type as compared to well-differentiated follicular and papillary carcinomas. The present paper aims to review the various aspects of this tumor type, from morphology to immunohistochemistry and molecular abnormalities from a practical and daily practice-oriented point of view.

Entities:  

Mesh:

Year:  2008        PMID: 18766471     DOI: 10.1007/s12022-008-9040-4

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  38 in total

1.  BRAF mutations typical of papillary thyroid carcinoma are more frequently detected in undifferentiated than in insular and insular-like poorly differentiated carcinomas.

Authors:  Paula Soares; Vítor Trovisco; Ana Sofia Rocha; Tália Feijão; Ana Paula Rebocho; Elsa Fonseca; Inês Vieira de Castro; José Cameselle-Teijeiro; Manuel Cardoso-Oliveira; Manuel Sobrinho-Simões
Journal:  Virchows Arch       Date:  2004-04-17       Impact factor: 4.064

2.  Poorly differentiated oxyphilic (Hurthle cell) carcinomas of the thyroid.

Authors:  M Papotti; B Torchio; L Grassi; A Favero; G Bussolati
Journal:  Am J Surg Pathol       Date:  1996-06       Impact factor: 6.394

3.  Insular carcinoma: a distinct de novo entity among follicular carcinomas of the thyroid gland.

Authors:  S Pilotti; P Collini; L Mariani; M Placucci; I Bongarzone; P Vigneri; S Cipriani; F Falcetta; R Miceli; M A Pierotti; F Rilke
Journal:  Am J Surg Pathol       Date:  1997-12       Impact factor: 6.394

Review 4.  Poorly differentiated oxyphilic (Hürthle cell) carcinoma arising in lingual thyroid: a case report and review of the literature.

Authors:  Juan Manuel Seoane; José Cameselle-Teijeiro; María Amparo Romero
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

5.  Another dissertation on poorly differentiated carcinomas: is it really necessary?

Authors:  R H Nishiyama
Journal:  Adv Anat Pathol       Date:  1999-09       Impact factor: 3.875

6.  N-ras mutation in poorly differentiated thyroid carcinomas: correlation with bone metastases and inverse correlation to thyroglobulin expression.

Authors:  F Basolo; F Pisaturo; L E Pollina; G Fontanini; R Elisei; E Molinaro; P Iacconi; P Miccoli; F Pacini
Journal:  Thyroid       Date:  2000-01       Impact factor: 6.568

7.  E-cadherin loss rather than beta-catenin alterations is a common feature of poorly differentiated thyroid carcinomas.

Authors:  A S Rocha; P Soares; E Fonseca; J Cameselle-Teijeiro; M C Oliveira; M Sobrinho-Simões
Journal:  Histopathology       Date:  2003-06       Impact factor: 5.087

8.  Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland.

Authors:  R Donghi; A Longoni; S Pilotti; P Michieli; G Della Porta; M A Pierotti
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

9.  Poorly differentiated forms of papillary thyroid carcinoma: distinctive entities or morphological patterns?

Authors:  S Pilotti; P Collini; A Manzari; E Marubini; F Rilke
Journal:  Semin Diagn Pathol       Date:  1995-08       Impact factor: 3.464

10.  Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients.

Authors:  Marco Volante; Stefania Landolfi; Luigi Chiusa; Nicola Palestini; Manuela Motta; Alessandra Codegone; Bruno Torchio; Mauro G Papotti
Journal:  Cancer       Date:  2004-03-01       Impact factor: 6.860

View more
  11 in total

1.  MicroRNA profile of poorly differentiated thyroid carcinomas: new diagnostic and prognostic insights.

Authors:  Matthias S Dettmer; Aurel Perren; Holger Moch; Paul Komminoth; Yuri E Nikiforov; Marina N Nikiforova
Journal:  J Mol Endocrinol       Date:  2014-03-06       Impact factor: 5.098

2.  Re-evaluation of histopathological factors affecting prognosis of differentiated thyroid carcinoma in an iodine-sufficient country.

Authors:  Iwao Sugitani; Kazuhisa Toda; Noriko Yamamoto; Atsuhiko Sakamoto; Yoshihide Fujimoto
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

3.  Poorly differentiated thyroid carcinoma: 5 years after the 2004 WHO classification of endocrine tumours.

Authors:  Marco Volante; Mauro Papotti
Journal:  Endocr Pathol       Date:  2010-03       Impact factor: 3.943

4.  Genetic alterations in the phosphoinositide 3-kinase/Akt signaling pathway confer sensitivity of thyroid cancer cells to therapeutic targeting of Akt and mammalian target of rapamycin.

Authors:  Dingxie Liu; Peng Hou; Zhi Liu; Guojun Wu; Mingzhao Xing
Journal:  Cancer Res       Date:  2009-08-25       Impact factor: 12.701

5.  Prognostic factors of papillary and follicular carcinomas in Japan based on data of kuma hospital.

Authors:  Yasuhiro Ito; Akira Miyauchi
Journal:  J Thyroid Res       Date:  2011-09-29

6.  Oncocytic variant of poorly differentiated thyroid carcinoma: "Is diagnosis possible by fine-needle aspiration?"

Authors:  Mine Onenerk; Sule Canberk; Pembegul Gunes; Murat Erkan; Gamze Z Kilicoglu
Journal:  Cytojournal       Date:  2016-10-13       Impact factor: 2.091

7.  Management and Prognostic Factors for Thyroid Carcinoma Showing Thymus-Like Elements (CASTLE): A Case Series Study.

Authors:  Rui Gao; Xi Jia; Ting Ji; Jinteng Feng; Aimin Yang; Guangjian Zhang
Journal:  Front Oncol       Date:  2018-10-26       Impact factor: 6.244

Review 8.  Poorly differentiated thyroid carcinoma : An underdiagnosed entity.

Authors:  M S Dettmer; A Schmitt; P Komminoth; A Perren
Journal:  Pathologe       Date:  2020-06       Impact factor: 1.011

9.  Poorly differentiated thyroid carcinoma: a retrospective clinicopathological study.

Authors:  Ghofrane Salhi Cherkaoui; Amal Guensi; Sara Taleb; Malika Ait Idir; Najwa Touil; Rita Benmoussa; Zaineb Baroudi; Nabil Chikhaoui
Journal:  Pan Afr Med J       Date:  2015-06-22

10.  The BH3 mimetic drug ABT-737 induces apoptosis and acts synergistically with chemotherapeutic drugs in thyroid carcinoma cells.

Authors:  Martina Broecker-Preuss; Nina Becher-Boveleth; Stefan Müller; Klaus Mann
Journal:  Cancer Cell Int       Date:  2016-04-02       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.